FFO
RMD icon

Fortitude Family Office’s ResMed RMD Stock Holding History

Fortitude Family Office’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.79K Sell
40
-12
-23% -$2.49K ﹤0.01% 885
2026
Q1 		$11.7K Buy
52
+13
+33% +$3.24K ﹤0.01% 599
2025
Q4 		$9.39K Sell
39
-16
-29% -$4.09K ﹤0.01% 598
2025
Q3 		$15.1K Buy
55
+2
+4% +$546 ﹤0.01% 459
2025
Q2 		$13.7K Buy
53
+23
+77% +$5.49K ﹤0.01% 464
2025
Q1 		$6.72K Hold
30
– – ﹤0.01% 647
2024
Q4 		$6.86K Hold
30
– – ﹤0.01% 749
2024
Q3 		$7.32K Hold
30
– – ﹤0.01% 652
2024
Q2 		$5.74K Hold
30
– – ﹤0.01% 540
2024
Q1 		$5.94K Hold
30
– – ﹤0.01% 533
2023
Q4 		$5.16K Buy
+30
New +$4.61K ﹤0.01% 615

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fortitude Family Office's RMD Position: Q2 2026 in Review

Fortitude Family Office reduced its ResMed (RMD) stake by 23% in Q2 2026, selling an estimated $2.49K and leaving 40 shares worth $7.79K. The position accounts for ﹤0.01% of the portfolio, ranked #885.

Fortitude Family Office first reported a position in RMD in Q4 2023 and has held it in 11 quarters since. The position peaked at $15.1K in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Fortitude Family Office held 40 shares of ResMed worth $7.79K as of Q2 2026.
  • Fortitude Family Office sold 12 ResMed shares in Q2 2026, an estimated $2.49K.
  • ResMed made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #885 holding.
  • Fortitude Family Office first reported a position in ResMed in Q4 2023 and has held it in 11 quarters since.
  • Fortitude Family Office's ResMed position peaked at $15.1K in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.